Neuromodulation Therapy Access Coalition

The Neuromodulation Therapy Access Coalition (NTAC) is a Washington, D.C.-based advocacy organization dedicated to ensuring patient access to advanced neuromodulation technologies. Representing leading medical device manufacturers such as Medtronic, Abbott, and Boston Scientific, the coalition focuses on influencing federal and state policy, securing favorable reimbursement terms, and navigating the legislative landscape. NTAC's primary mission is to protect and expand coverage for life-changing therapies, including spinal cord stimulation (SCS) and deep brain stimulation (DBS), by demonstrating their clinical efficacy and economic value to payers and government agencies. The organization plays a critical role in reducing barriers for patients suffering from chronic pain and neurological movement disorders.